✦ LIBER ✦

Recent advancement on autoantigens, autoantibodies and inflammatory cells in subepidermal autoimmune bullous diseases

✍ Scribed by Jianguo Huanga; Qiying Gonga; Guiming Lib

Book ID: 117696495
Publisher: Chinese Electronic Periodical Services
Year: 2007
Tongue: English
Weight: 129 KB
Volume: 21
Category: Article
ISSN: 1007-4376
DOI: 10.1016/s1007-4376(07)60031-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P276 LOW RISK FOR DEVELOPING AUTOANTIBOD

P276 LOW RISK FOR DEVELOPING AUTOANTIBODIES AND AUTOIMMUNE DISORDERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES ON LONG TERM TREATMENT WITH INFLIXIMAB

✍ G.J. Mantzaris; S. Ballas; A. Roussos; S. Koilakou; A. Christidou; C. Kalantzis; 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 67 KB

Stem cells in liver diseases and cancer:

Stem cells in liver diseases and cancer: Recent advances on the path to new therapies

✍ C. Bart Rountree; Lopa Mishra; Holger Willenbring 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

Treatment with a consensus peptide based

Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus

✍ Bevra H. Hahn; Ram R. Singh; Weng Kee Wong; Betty P. Tsao; Ken Bulpitt; Fanny M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Objective: To test the hypothesis that an artificial peptide, based on an algorithm describing t cell stimulatory sequences from the vh regions of murine igg antibodies to dna, is an effective tolerogen in vivo in the (nzb/nzw)f1 (bwf1) mouse model of systemic lupus erythematosus. ## Methods: